Young Journalists Club | Latest news of Iran and world

News ID: 4283
Iran » Iran
Publish Date: 15:29 - 31 May 2014
Tehran, YJC. Head of Food and Drug Administration says Interferon β made domestically will be available cheaper.

Dr. Rasoul Dinarvand who was speaking at the closing ceremony held for patients with MS in Milad Tower on Friday evening said "The patients who used to spend something between Rls500 to 900 thousand will pay only Rls25 to 45 thousand starting Saturday.”

Pointing out that around 30 thousand people use the drug he said "The drug is being produced in three formulas around the world, all three of which are also made in Iran,” Mehr News Agency reports.

Dinarvand further said "The patients who use the Iranian version will receive 95 percent support from the Health Ministry and insurance companies.”

"Although there is no problem with the Iran-made drug and it can serve the patients well, there are some physicians who prescribe the imported versions. There are less than 8 thousand patients using the foreign versions. Based on their accounting formulae, insurance companies cover the imported drug up to the price of the domestic one,” he mentioned.

"So that patients using imported drugs are burdened less, the Health Ministry allocated Rls1,000 billion as support. Although subsidies this much is a lot, the patients still pay a lot out of their pockets, so much so that they still have to spend about Rls6 million for MS drugs,” he said.

Your Comment
* Comment:
* captcha: